AUSTIN, Texas, Nov. 18, 2025 /PRNewswire/ -- Alafair Biosciences, Inc., a medical device company redefining soft-tissue protection in orthopedic surgery, announced today the first clinical use of its ...
CHICAGO -- A no-scalpel vasectomy passed a preliminary clinical test, achieving near-100% azoospermia within 2 weeks and maintaining the status to day 30 in the first men to undergo the procedure.
Decision based on data involving use of SpaceOAR® hydrogel to protect surrounding tissue during radiotherapy to treat prostate cancer. BEDFORD, Mass.--(BUSINESS WIRE)--Augmenix, Inc., a medical ...
Lead product GelrinC®, a hydrogel synchronized erosion and resorbable implant, the only restorative product for knee ...
BEDFORD, Mass.--(BUSINESS WIRE)-- Augmenix, Inc. is pleased to announce that the company’s leading product, SpaceOAR hydrogel, is now available to millions of American men covered under Medicare, ...
For many people, the sound of their own voice feels like part of who they are. When that voice turns rough or disappears ...
VersaCoat Flowable Hydrogel, developed from Alafair's proprietary VersaCore™ Hydrogel Technology, uses the same collagen-free hyaluronic acid and alginate formulation as VersaWrap ® Hydrogel Sheet ...
The MarketWatch News Department was not involved in the creation of this content. AUSTIN, Texas, Nov. 18, 2025 /PRNewswire/ -- Alafair Biosciences, Inc., a medical device company redefining ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback